Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę "związki kompleksowe" wg kryterium: Temat


Wyświetlanie 1-10 z 10
Tytuł:
Zastosowanie związków kompleksowych platyny, palladu i kobaltu w medycynie. Cz. 1
Application of coordination compounds of platinum, palladium and cobalt in medicine. Part 1
Autorzy:
Pawlak, Marta
Drzeżdżon, Joanna
Jacewicz, Dagmara
Powiązania:
https://bibliotekanauki.pl/articles/1409835.pdf
Data publikacji:
2020
Wydawca:
Polskie Towarzystwo Chemiczne
Tematy:
związki kompleksowe platyny
związki kompleksowe palladu
związki kompleksowe kobaltu
leki przeciwnowotworowe
coordination compounds of platinum
coordination compounds of palladium
coordination compounds of cobalt
anticancer drugs
Opis:
The complex compounds containing metal ions are a group of compounds widely used in medicine. More and more metals are also being used to create cancer drugs or to help with other very serious diseases. Anticancer drugs are a particular use of complex compounds. Many thousands of platinum(II) compounds have been synthesized in cancer therapy, but only six of them have found use in the treatment of cancer. The most popular and the most commonly used compound is cisplatin, it has become the basis for the treatment of bladder, cervical, head, esophagus and many cancers occurring in children. The mechanism of action of platinum(II) and platinum(IV) compounds against cancer cells is to inhibit DNA replication, then RNA transcription and stop the G2 phase of the cell cycle and lead to programmed cell death or apoptosis. Coordination compounds containing more than one metal ion in their composition open new possibilities in the fight against cancer. Pt-DNA connections created by compounds containing at least two metal atoms are different from those formed by cisplatin. The basic dinuclear structure allows for great flexibility in forming DNA-DNA or DNA-protein bonds. The cobalt(III) complexes began to be used to image areas of hypoxia in cancer cells. It is believed, that cobalt(III) complexes undergo bioreduction, which leads to the release of the labile cobalt(II) complex and one or more bioactive ligands. Studies on nitro-Co(III) complexes containing acetylacetone and a nitrogen mustard ligand have shown that it is a particularly effective anti-cancer drug. Due to the fact that many people have cancer new effective anti-cancer drugs with low toxicity and no side effects are still being sought.
Źródło:
Wiadomości Chemiczne; 2020, 74, 11-12; 797-822
0043-5104
2300-0295
Pojawia się w:
Wiadomości Chemiczne
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Właściwości katalityczne i biomedyczne związków zawierających jony rutenu (II) oraz Rutenu (III)
Catalytic and biomedical properties of compound containing ruthenium (II) and ruthenium (III) ions
Autorzy:
Pobłocki, Kacper
Pawlak, Marta
Walczak, Juliusz
Drzeżdżon, Joanna
Jacewicz, Dagmara Elżbieta
Powiązania:
https://bibliotekanauki.pl/articles/27310039.pdf
Data publikacji:
2023
Wydawca:
Polskie Towarzystwo Chemiczne
Tematy:
związki kompleksowe Ru(II)
związki kompleksowe Ru(III)
właściwości biomedyczne
właściwości katalityczne
Ru(II) complex compounds
Ru(III) complex compounds
biomedical properties
catalytic properties
Opis:
Ruthenium complexes appear in scientific publications mainly as catalysts in the olefins metathesis process. In this review, we want to indicate the research niche regarding the use of ruthenium(II) and ruthenium(III) complexes in other catalytic processes, i.e. polymerization or epoxidation of olefins and depolymerization. We would like to combine the catalytic properties of ruthenium(II,III) complex compounds with their biomedical activity due to the growing problem of drug resistance (including antibiotic resistance). Scientists have been designing new metallopharmaceuticals exhibiting biological activity for several years, therefore this requires a critical review of the literature. The main goal of designing new metallodrugs is to create compounds with new or stronger biological properties compared to free ligands. Ruthenium compounds are considered potential substitutes for known drugs. In particular, Ru(II) and Ru(III) based complexes have reduced toxicity and can be tolerated in vivo. In addition, a wide spectrum of ruthenium oxidation states, a different mechanism of action and the kinetics of ligand substitution increase the advantage over coordination complex compounds based on platinum. In conclusion, in this review, we will focus on the latest reports from the literature on the catalytic properties and biomedical activity of ruthenium(II) and ruthenium(III) chemical compounds.
Źródło:
Wiadomości Chemiczne; 2023, 77, 5-6; 569--595
0043-5104
2300-0295
Pojawia się w:
Wiadomości Chemiczne
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Aminy biogenne w aspekcie ich roli w organizmach żywych
Biogenic amines in their role in living systems
Autorzy:
Jastrząb, R.
Tylkowski, B.
Powiązania:
https://bibliotekanauki.pl/articles/171885.pdf
Data publikacji:
2016
Wydawca:
Polskie Towarzystwo Chemiczne
Tematy:
poliaminy
aminy biogenne
związki kompleksowe
nowotwory
polyamines
biogenic amines
coordination compounds
tumors
Opis:
Although polyamines (PA) belong to relatively simple aliphatic substances, their role in life processes of animals and plants is of key importance [1–5]. The group of the most important amines, called biogenic ones includes: Spermine (Spm): H2N(CH2)3NH(CH2)4NH(CH2)3NH2 Spermidine (Spd): H2N(CH2)3NH(CH2)4NH2 Putrescine (Put): H2N(CH2)4NH2. Of secondary importance are homologues of biogenic amines, occurring in lower contents in living organisms [2, 6–8]: 1,3-diaminopropan: H2N(CH2)3NH2 Cadaverine: H2N(CH2)5NH2 Homospermidine: H2N(CH2)4NH(CH2)4NH2 Norspermine (3,3,3-tet): H2N(CH2)3NH(CH2)3NH(CH2)3NH2 Thermospermine: H2N(CH2)3NH(CH2)4NH(CH2)4NH2 Caldopentamine: H2N(CH2)3NH(CH2)3NH(CH2)3NH(CH2)3NH2. The first polyamine discovered in a living organism was tetramine, a spermine crystallised out of sperm in 1678 by Van Leewenkeuk [9]. Putrescine was discovered in the end of the 19th century in microbes and then triamine: spermidine was discovered in the beginning of the 20th century [2]. Later studies have shown that in animal cells spermidine and spermine occur at elevated levels, while in prokaryotes spermidine and putrescine contents are dominant. Putrescine, spermidine, 1,3-diaminopropan, homospermidine, norspermidine, and norspermine have been found in many gramnegative bacteria and algae [7, 10, 11]. Total concentration of PA in living organisms is on the order of millimols, however, the concentration of free polyamines is much lower. A low level of free amines follows from the fact that they are involved in noncovalent interactions with biomolecules occurring in living organisms such as nucleic acids, proteins, or phospholipids. High concentrations of non-bonded polyamines have been detected first of all in young molecules in the process of growth, in particular in rapidly proliferating cancer cells [6, 12]. Elevated levels of free polyamines have been observed, e.g. in breast, colon, lung, prostate, and skin tumours, accompanied by changed levels of enzymes responsible for biosynthesis and catabolism of polyamines. Because of the increased level of free polyamines and a tendency of their interaction with nucleic acids and other bioligands, these compounds have become objects of intense study [1, 13–19]. There is no doubt that the regulation of biosynthesis of polyamines and catabolism is one of the most important pathways in the search strategy for chemoprevention and chemotherapeutic drugs [14, 15, 20–36]. The present state of knowledge of these processes, their significance in biological systems, and their application in medicine are presented in subsequent sections of this chapter.
Źródło:
Wiadomości Chemiczne; 2016, 70, 1-2; 57-79
0043-5104
2300-0295
Pojawia się w:
Wiadomości Chemiczne
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Zastosowanie związków kompleksowych rutenu, złota, wanadu, chromu, bizmutu, technetu w medycynie. Cz. 2
Application of coordination compounds of ruthenium, gold, vanadium, chromium, bismuth, technetium in medicine. Part 2
Autorzy:
Pawlak, Marta
Drzeżdżon, Joanna
Jacewicz, Dagmara
Powiązania:
https://bibliotekanauki.pl/articles/1409708.pdf
Data publikacji:
2020
Wydawca:
Polskie Towarzystwo Chemiczne
Tematy:
związki kompleksowe
radiofarmaceutyki
obrazowanie medyczne
właściwości hipoglikemiczne
complex compounds
radiopharmaceuticals
medical imaging
hypoglycemic properties
Opis:
In this review, the most important complex compounds of ruthenium, gold, vanadium, chromium, bismuth, technetium were selected, and then their most important applications were described in medicine. Ruthenium has been identified as a metal with potential medical use, useful in cancer chemotherapy. The possibility of using its chemical behavior by developing complexes activated for cytotoxic activity through a mechanism of reduction in tumor tissue was discovered. Among the new anti-cancer drugs based on complex compounds, gold compounds have gained a lot of interest. This is due to their strong inhibitory effect on the growth of cancer cells and the observation that many compounds inhibit the enzyme thioredoxin reductase. This enzyme is important for the proliferation of cancerous tissues, and its inhibition is associated with the release of anti-mitochondrial effects. Clinical tests have shown that vanadium compounds can be used as anti-diabetic drugs with low toxicity. However, the therapeutic concentration range is very narrow, just a few micromoles of the compound are enough to cause apoptosis, necrosis and inflammation of healthy cells. Chromium improves the glucose system in people with hypoglycemia or hyperglycemia. Vanadium compounds mainly used to create potential drugs are inorganic compounds such as vanadates(V), vanadyl cation(IV), vanadium oxide(V) and a number of compounds containing organic ligands. Among the metal complexes, chromium(III) picolinate has successfully become a nutrient used to prevent high blood sugar levels. One of the most commonly used bismuth(III) compounds is bismuth subsalicylate. It is one of the few bismuth compounds regularly used to treat various gastrointestinal complaints, including duodenal ulcers. 99mTc injected into the body, depending on its chemical form and molecular structure, concentrates in the examined organ and emits a quantum that allows imaging of the organ through flat scintigraphic or emission processes. The role of complex compounds in medical imaging is largely based on the creation of radiopharmaceuticals for early detection of diseases and cancer radiotherapy. Radiopharmaceuticals are radionuclide-containing drugs and are routinely used in nuclear medicine to diagnose or treat a variety of diseases.
Źródło:
Wiadomości Chemiczne; 2020, 74, 11-12; 823-851
0043-5104
2300-0295
Pojawia się w:
Wiadomości Chemiczne
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Związki kompleksowe chromu(III), wanadu(IV) i kobaltu(II) jako nowe prekatalizatory polimeryzacji olefin
Chromium(III), vanadium(IV) and cobalt(II) complex compounds as new olefin polymerization precatalysts
Autorzy:
Drzeżdżon, Joanna
Powiązania:
https://bibliotekanauki.pl/articles/171572.pdf
Data publikacji:
2020
Wydawca:
Polskie Towarzystwo Chemiczne
Tematy:
chrom
wanad
kobalt
związki kompleksowe
prekatalizatory
polimeryzacja
chromium
vanadium
cobalt
complex compounds
precatalysts
polymerization
Opis:
The olefin polymerization catalysts constitute a large group of various compounds. Metallocene complexes are the largest part of this group. However, due to the instability at industrial plastics temperatures and the decomposition of complexes after MAO (or MMAO) activation, they have been partly replaced by non-metallocene compounds. This article concerns the studies on new non- metallocene precatalysts for the olefin polymerization and oligomerization. The report focuses on the structure and the catalytic activities of the complexes of chromium(III), vanadium(IV) and cobalt(II) with the following ligands: dipicolinate, 2-pyridinecarboxylate, oxalate, oxydiacetate, iminodiacetate, 2,2’- bipyridine, 4,4’-dimethoxy-2,2’-bipyridine, 1,10-phenantroline. These complex compounds are highly active precatalysts for olefin polymerization and oligomerization. The complexes: [Cr(dipic)2][Cr(bipy)(dipic)H20]-2H20 and [Cr(dipic) 2]Hdmbipy2.5H20 deserve special attention because they are new type of the precatalysts i.e. organic salt type complexes composed both of organic cations and anions. These compounds are not only interesting because of their structure but also because of their high catalytic activity.
Źródło:
Wiadomości Chemiczne; 2020, 74, 5-6; 423-437
0043-5104
2300-0295
Pojawia się w:
Wiadomości Chemiczne
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Właściwości antyoksydacyjne, antybakteryjne i przeciwgrzybicze związków kompleksowych miedzi(II)
Antioxidant, antibacterial and antifungal properties of complex compounds of copper(II)
Autorzy:
Piotrowska, A.
Drzeżdżon, J.
Jacewicz, D.
Chmurzyński, L.
Powiązania:
https://bibliotekanauki.pl/articles/171722.pdf
Data publikacji:
2017
Wydawca:
Polskie Towarzystwo Chemiczne
Tematy:
związki kompleksowe
miedź(II)
antyoksydanty
aktywność antybakteryjna
aktywność przeciwgrzybicza
copper(II) complexes
antioxidants
antibacterial activity
antifungal activity
Opis:
Since late 1930s copper has been recognized as an essential trace metal in living organisms. Copper(II) cation plays the role as a coordination center not only in the single-nuclear complexes, but also in the multinuclear coordination compounds with a particular emphasis on the polymers as ligands. The selected complex compounds of copper(II) with ligands which are organic and inorganic species have been characterized taking into account their physico-chemical properties. In addition, the complex compounds containing ligands such as Schiff ’s bases, hydrocarbons, organic bases, and also polycarboxylic anions: oxydiacetate, thiodiacetate, iminodiacetate and dipicolinate have been described considering their role in the biological systems. Nowadays tested coordination compounds of copper(II) have interesting antibacterial activities against bacteria strains that are antagonistic to the human. The antibacterial activity of copper(II) complex is stronger than some of the known antibacterial substances e.g. ciprofloxacin. In addition, copper(II) complex compounds exhibit a 64-fold greater antimicrobial properties than copper(II) chloride. Moreover, these compounds have antifungal and antioxidant properties. The activities of antibacterial, antifungal, and antioxidant complex compounds of copper( II) have been compared to the reactivities of these compounds with complexes used as reference substances, e.g. L-ascorbic acid, in the assay using nitrotetrazolium blue.
Źródło:
Wiadomości Chemiczne; 2017, 71, 3-4; 219-240
0043-5104
2300-0295
Pojawia się w:
Wiadomości Chemiczne
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Kompleksy peptydów z jonami Cu2+ jako mimetyki dysmutazy ponadtlenkowej
Peptides complexes with Cu2+ ions as mimetics of superoxide dismutase
Autorzy:
Pieniężna, Aleksandra
Kotynia, Aleksandra
Powiązania:
https://bibliotekanauki.pl/articles/1409838.pdf
Data publikacji:
2020
Wydawca:
Polskie Towarzystwo Chemiczne
Tematy:
dysmutaza ponadtlenkowa
związki kompleksowe miedzi
właściwości przeciwutleniające
peptydy
reszta histydylowa
superoxide dismutase
copper complexes
antioxidant properties
peptides
histidyl residue
Opis:
Disturbances in the balance between the rates of reactive oxygen species formation and the ability of cells to neutralize them are often cause dysfunction in the human body. Therefore the research on natural antioxidant systems protecting cells against destruction is very important. One of such system acting in human organism is superoxide dismutase (SOD), which is responsible for degradation of the superoxide radical anion into molecular oxygen and hydrogen peroxide. The SOD was discovered in the 40s of the twentieth century, and since then there has been a lot of research on it. Currently, these studies mainly concern searching compounds that may mimic the enzymatic activity of this protein. Groups of these compounds include, for example, peptides, salens, metalloporphyrins or vitamin derivatives. For the proper functioning of the CuZnSOD enzyme necessary is the active center containing metal ions (Rys.2). They mainly coordinate to the nitrogens of the imidazole histidine residues. Due to the fact that peptides may have many histidyl residues in their structure, they could rather than others coordinate with metal ions and they are promising compounds in studies on CuZnSOD mimetics. Therefore we will consider peptide complexes with copper(II) and zinc(II) ions as potential mimetics of superoxide dismutase. In presented review article we have focused on the differences in the coordination manner of divalent copper ions by linear, cyclic and branched peptides. As well as the possibility of creating hetero- and homo-dinuclear complexes are discussed. Moreover we have compared the ability of these complexes to decomposition the superoxide radical with activity of native enzyme.
Źródło:
Wiadomości Chemiczne; 2020, 74, 11-12; 735-759
0043-5104
2300-0295
Pojawia się w:
Wiadomości Chemiczne
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Wybrane właściwości fizykochemiczne polikarboksylanowych związków kompleksowych kobaltu(II), niklu(II), miedzi(II) i oksowanadu(IV)
Selected physicochemical properties of polycarboxylate cobalt(II), nickel(II), copper(II) and oxidovanadium(IV) complex compounds
Autorzy:
Piotrowska-Kirschling, A.
Drzeżdżon, J.
Chmurzyński, L.
Jacewicz, D.
Powiązania:
https://bibliotekanauki.pl/articles/171735.pdf
Data publikacji:
2018
Wydawca:
Polskie Towarzystwo Chemiczne
Tematy:
polikarboksylanowe związki kompleksowe
kinetyka
metoda stopped-flow
właściwości antyoksydacyjne
woltamperometria cykliczna
polycarboxylate complexes
kinetics
stopped-flow method
antioxidant activity
cyclic voltammetry
Opis:
Cobalt(II), nickel(II), copper(II) and oxidovanadium(IV) cations are coordination centers in many polycarboxylate complexes [1‒16]. A number of coordination compounds of transition metal ions with such ligands as polycarboxylate anions and heterocyclic organic ligands, e.g. 1,10-phenanthroline (phen) or 2,2’-bipyridine (bipy) have been examined for their biological properties [3‒16]. Their selected structures and physicochemical properties have been described in the first chapter. The polycarboxylate coordination compounds of cobalt(II), nickel(II), copper(II) and oxidovanadium(IV) have interesting antioxidant, antibacterial and antifungal activities. The antioxidant properties of polycarboxylate complexes of Co(II), Ni(II), Cu(II) and VO(IV) with 4-picoline, 1,10-phenanhroline and 2,2’-bipyridine have been investigated towards the superoxide anion radical using the nitro blue tetrazolium chloride (NBT) test and the cyclic voltammetry (CV). Their antibacterial and antifungal activities have been tested against bacteria and fungus strains that are antagonistic to the human. The determined biological properties of the oxydiacetate Co(II), Ni(II), VO(IV) complexes with bipy/phen, the thiodiacetate VO(IV) and the iminodiacetate Cu(II) complexes have been compared with these of L-ascorbic acid, which is chemical compounds commonly used as the reference antioxidant substance. Consequently, the comparison of antioxidant properties of selected cobalt( II), nickel(II), copper(II) and oxidovanadium(IV) polycarboxylate compounds is described in this work (Section 3, Tab. 1‒4). The kinetics of substitution reactions of selected copper(II) polycarboxylate complex compounds were monitored using the stopped-flow method in various reaction conditions (concentration of complex, temperature, solvent) (Rys. 5‒6) [5, 6]. The obtained results of the kinetic studies of the substitution reactions of [Cu(tda)]n with 2,2’-bipyridine in aqueous surfactants solvents: sodium dodecyl sulfate (SDSaq) and hexadecyl trimethyl- ammonium bromide (CTABaq) at 298.15 K (25 °C) are presented.
Źródło:
Wiadomości Chemiczne; 2018, 72, 11-12; 797-814
0043-5104
2300-0295
Pojawia się w:
Wiadomości Chemiczne
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Asymetryczne przeniesienie wodoru do ketonów katalizowane związkami Rutenu(II) i Rodu(III)
Asymmetric transfer hydrogenation of ketones catalyzed by Ruthenium(II) and Rhodium(III) complexes
Autorzy:
Karczmarska-Wódzka, A.
Kołodziejska, R.
Studzińska, R.
Wróblewski, M.
Powiązania:
https://bibliotekanauki.pl/articles/172550.pdf
Data publikacji:
2012
Wydawca:
Polskie Towarzystwo Chemiczne
Tematy:
transfer wodoru asymetryczny
związki kompleksowe Ru(II) i Rh(III)
chiralne ligandy
prochiralne związki karbonylowe
asymmetric transfer hydrogenation
Ru(II) and Rh(III) complexes
chiral ligands
prochiral carbonyl compounds
Opis:
Asymmetric hydrogen transfer (ATH) is one of the methods of stereoselective reduction of prochiral carbonyl compounds (Scheme 6). Complexes of the platinum group metals (Noyori catalysts) are the most common catalysts for AT H reactions. The specific structure of the Noyori catalyst allows to activate two hydrogen atoms. These atoms are transferred from donor to acceptor in the form of hydride ion and proton (Scheme 1). Depending on the used catalyst the transfer hydrogenation of ketons can proceed by direct and indirect transfer mechanism. The direct hydride transfer from a donor to an acceptor proceeds via a six-membered transition state (3) (Scheme 2). The indirect hydride transfer proceeds through the formation of an intermediate metal hydride. A monohydride (HLnMH) and or a dihydride (LnMH2) can be formed depending on the catalyst that is used (Scheme 3). In the monohydride route, the reduction proceeds in the inner sphere of the metal (four-membered transition state (4)) or in the outer sphere of the metal (six-membered transition state (5)) (Scheme 4). The proposed reduction of carbonyl compounds in the AT H reaction by Noyori catalysts uses the mechanism of the hydride ion and proton transfer from the donor to the catalyst and the formation of the monohydride. In the indirect transfer hydrogenation the hydride ion and proton are transferred from the monohydride to the acceptor (Scheme 5, 7). AT H reactions that lead to chiral alcohols are conducted in organic solvents or in water. Hydrogen donors most often used in organic solvent reactions are propan-2-ol or an azeotropic mixture of formic acid and triethylamine (Tab. 1, 6). Sodium formate is usually used as hydrogen donor in the reactions conducted in water. Yield and enantioselectivity of the reaction depend on many factors the most important of which are: the structure of a substrate, hydrogen donor and solvent that were used, the reaction time, substrate concentration, and the S/C ratio [2]. In the case of asymmetric reduction conducted in water the solvent pH is also of great importance [3, 7, 8]. An optimal pH range depends on the type of a catalyst [7, 8]. AT H reactions conducted in water are distinguished by a shorter reaction time and higher enantioselectivity than the reactions conducted in organic solvents. In addition, catalysts used in the AT H reactions are more stable in water allowing reuse of the catalyst without loss of its activity. This paper presented examples of the use of specific catalysts in asymmetric reactions of hydrogen transfer. In particular, I drew attention to the reactions running in the aquatic environment due to the above-mentioned advantages of this solvent. The authors focused specifically on bifunctional catalysts based on Ru(II) and Rh(III) on the account of wide usage of the catalysts of that type in AT H reactions in water and their good performance [8, 9, 15, 16, 17, 19, 20, 21, 22]. p-Cymene is the most common aromatic ligand in catalysts based on Ru(II) while in the case of catalysts with Rh(III) the most common is anionic pentamethylcyclopentadienyl ligand. In both cases the second most common ligands are diamines or amino alcohols (Scheme 8). There are better performance and enantioselectivity when diamines are used as ligands. Attempts to replace diamines and amino alcohols by Schiff bases (Scheme 13) in the catalysts containing Rh(III) proved poor results due to a very low enantioselectivity of conducted reactions (Tab. 7).
Źródło:
Wiadomości Chemiczne; 2012, 66, 3-4; 273-295
0043-5104
2300-0295
Pojawia się w:
Wiadomości Chemiczne
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Związki kompleksowe na bazie Gd(III), W(IV), Mn(II), Eu(III) i 99mTc wykorzystywane w diagnostyce medycznej
Complex compounds based on Gd(III), W(IV), Mn(II), Eu(III) and 99mTc used in medical diagnostics
Autorzy:
Pobłocki, Kacper
Drzeżdżon, Joanna
Jacewicz, Dagmara Elżbieta
Powiązania:
https://bibliotekanauki.pl/articles/2200431.pdf
Data publikacji:
2022
Wydawca:
Polskie Towarzystwo Chemiczne
Tematy:
obrazowanie medyczne
związki kompleksowe
magnetyczny rezonans jądrowy
tomografia emisyjna pojedynczego fotonu
rentgenografia
obrazowanie optyczne
medical imaging
complex compounds
magnetic resonance imaging
single-photon emission computed tomography
rentgenography
optical imaging
Opis:
Recently, hospitals have undergone major changes. Minimally invasive surgery is becoming more common, and numerous innovations are emerging, such as interventional radiology (IVR) and hybrid surgery. In order to keep pace with changes in this extremely dynamic field, scientist keep working on the development of imaging technology and the improvement of image display devices and new compounds acting as contrast agent (CA). In medicine, metals are used for diagnostic and therapeutic purposes. Inorganic elements are increasingly used as contrast agents in medical imaging due to their unique physicochemical properties. In this review, we would like to focus on the latest literature reports that contain information on Gd(III), W(IV), Mn(II), Eu(III) and 99mTc used in medical diagnostics.
Źródło:
Wiadomości Chemiczne; 2022, 76, 9-10; 803--823
0043-5104
2300-0295
Pojawia się w:
Wiadomości Chemiczne
Dostawca treści:
Biblioteka Nauki
Artykuł
    Wyświetlanie 1-10 z 10

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies